BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 27033304)

  • 1. Emerging role of Lon protease as a master regulator of mitochondrial functions.
    Pinti M; Gibellini L; Nasi M; De Biasi S; Bortolotti CA; Iannone A; Cossarizza A
    Biochim Biophys Acta; 2016 Aug; 1857(8):1300-1306. PubMed ID: 27033304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A structure and function relationship study to identify the impact of the R721G mutation in the human mitochondrial lon protease.
    Sha Z; Montano MM; Rochon K; Mears JA; Deredge D; Wintrode P; Szweda L; Mikita N; Lee I
    Arch Biochem Biophys; 2021 Oct; 710():108983. PubMed ID: 34228963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CODAS syndrome is associated with mutations of LONP1, encoding mitochondrial AAA+ Lon protease.
    Strauss KA; Jinks RN; Puffenberger EG; Venkatesh S; Singh K; Cheng I; Mikita N; Thilagavathi J; Lee J; Sarafianos S; Benkert A; Koehler A; Zhu A; Trovillion V; McGlincy M; Morlet T; Deardorff M; Innes AM; Prasad C; Chudley AE; Lee IN; Suzuki CK
    Am J Hum Genet; 2015 Jan; 96(1):121-35. PubMed ID: 25574826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective mitochondrial protease LonP1 can cause classical mitochondrial disease.
    Peter B; Waddington CL; Oláhová M; Sommerville EW; Hopton S; Pyle A; Champion M; Ohlson M; Siibak T; Chrzanowska-Lightowlers ZMA; Taylor RW; Falkenberg M; Lightowlers RN
    Hum Mol Genet; 2018 May; 27(10):1743-1753. PubMed ID: 29518248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in LONP1, a mitochondrial matrix protease, cause CODAS syndrome.
    Dikoglu E; Alfaiz A; Gorna M; Bertola D; Chae JH; Cho TJ; Derbent M; Alanay Y; Guran T; Kim OH; Llerenar JC; Yamamoto G; Superti-Furga G; Reymond A; Xenarios I; Stevenson B; Campos-Xavier B; Bonafé L; Superti-Furga A; Unger S
    Am J Med Genet A; 2015 Jul; 167(7):1501-9. PubMed ID: 25808063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare and de novo variants in 827 congenital diaphragmatic hernia probands implicate LONP1 as candidate risk gene.
    Qiao L; Xu L; Yu L; Wynn J; Hernan R; Zhou X; Farkouh-Karoleski C; Krishnan US; Khlevner J; De A; Zygmunt A; Crombleholme T; Lim FY; Needelman H; Cusick RA; Mychaliska GB; Warner BW; Wagner AJ; Danko ME; Chung D; Potoka D; Kosiński P; McCulley DJ; Elfiky M; Azarow K; Fialkowski E; Schindel D; Soffer SZ; Lyon JB; Zalieckas JM; Vardarajan BN; Aspelund G; Duron VP; High FA; Sun X; Donahoe PK; Shen Y; Chung WK
    Am J Hum Genet; 2021 Oct; 108(10):1964-1980. PubMed ID: 34547244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opitz award-winning paper details genetic cause of CODAS syndrome: Research points to new categories of rare disorder.
    Am J Med Genet A; 2016 Oct; 170(10):2497-8. PubMed ID: 27643968
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical features of LONP1-related infantile cataract.
    Khan AO; AlBakri A
    J AAPOS; 2018 Jun; 22(3):229-231. PubMed ID: 29408517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation in the proteolytic domain of LONP1 causes atypical CODAS syndrome.
    Inui T; Anzai M; Takezawa Y; Endo W; Kakisaka Y; Kikuchi A; Onuma A; Kure S; Nishino I; Ohba C; Saitsu H; Matsumoto N; Haginoya K
    J Hum Genet; 2017 Jun; 62(6):653-655. PubMed ID: 28148925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of the lon protease in mitochondrial maintenance and the significance of declining lon in aging.
    Ngo JK; Davies KJ
    Ann N Y Acad Sci; 2007 Nov; 1119():78-87. PubMed ID: 18056957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year follow-up outcomes of comprehensive rehabilitation in Korean siblings with cerebral, ocular, dental, auricular, skeletal anomalies (CODAS) syndrome: A case report.
    Yoo SD; Han YR; Kim DH; Lee SA
    Medicine (Baltimore); 2019 Jun; 98(23):e15908. PubMed ID: 31169704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial Lon Protease and Cancer.
    Lu B
    Adv Exp Med Biol; 2017; 1038():173-182. PubMed ID: 29178076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lon in maintaining mitochondrial and endoplasmic reticulum homeostasis.
    Yang J; Chen W; Zhang B; Tian F; Zhou Z; Liao X; Li C; Zhang Y; Han Y; Wang Y; Li Y; Wang GQ; Shen XL
    Arch Toxicol; 2018 Jun; 92(6):1913-1923. PubMed ID: 29721585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multitasking in the mitochondrion by the ATP-dependent Lon protease.
    Venkatesh S; Lee J; Singh K; Lee I; Suzuki CK
    Biochim Biophys Acta; 2012 Jan; 1823(1):56-66. PubMed ID: 22119779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ATPase Inhibitory Factor 1 (IF1): A master regulator of energy metabolism and of cell survival.
    García-Bermúdez J; Cuezva JM
    Biochim Biophys Acta; 2016 Aug; 1857(8):1167-1182. PubMed ID: 26876430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards the control of intracellular protein turnover: mitochondrial Lon protease inhibitors versus proteasome inhibitors.
    Bayot A; Basse N; Lee I; Gareil M; Pirotte B; Bulteau AL; Friguet B; Reboud-Ravaux M
    Biochimie; 2008 Feb; 90(2):260-9. PubMed ID: 18021745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biology of Lonp1: More than a mitochondrial protease.
    Gibellini L; De Gaetano A; Mandrioli M; Van Tongeren E; Bortolotti CA; Cossarizza A; Pinti M
    Int Rev Cell Mol Biol; 2020; 354():1-61. PubMed ID: 32475470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix proteases in mitochondrial DNA function.
    Matsushima Y; Kaguni LS
    Biochim Biophys Acta; 2012; 1819(9-10):1080-7. PubMed ID: 22172992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial Lon protease at the crossroads of oxidative stress, ageing and cancer.
    Pinti M; Gibellini L; Liu Y; Xu S; Lu B; Cossarizza A
    Cell Mol Life Sci; 2015 Dec; 72(24):4807-24. PubMed ID: 26363553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial Lon protease regulates mitochondrial DNA copy number and transcription by selective degradation of mitochondrial transcription factor A (TFAM).
    Matsushima Y; Goto Y; Kaguni LS
    Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18410-5. PubMed ID: 20930118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.